NASDAQ · IPHA

Innate Pharma S.A. ADS financials

$1.60−5.88%

Close Sep 29, 2026 · split-adjusted

Innate Pharma S.A. ADS has no annual financial statements on file. Funds and some foreign issuers do not file them.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology